Biliary stone disease in patients receiving somatostatin analogs for neuroendocrine neoplasms. A retrospective observational study

2019 ◽  
Vol 51 (5) ◽  
pp. 689-694 ◽  
Author(s):  
Nicole Brighi ◽  
Giuseppe Lamberti ◽  
Ilaria Maggio ◽  
Lisa Manuzzi ◽  
Claudio Ricci ◽  
...  
Keyword(s):  
Observational Study ◽  
Somatostatin Analogs ◽  
Stone Disease ◽  
Retrospective Observational Study ◽  
Neuroendocrine Neoplasms ◽  
Biliary Stone

scholarly journals Biliary Stone Disease in Patients with Neuroendocrine Tumors Treated with Somatostatin Analogs: A Multicenter Study

2019 ◽  
Vol 25 (3) ◽  
pp. 259-265 ◽  
Author(s):  
Nicole Brighi ◽  
Francesco Panzuto ◽  
Roberta Modica ◽  
Fabio Gelsomino ◽  
Manuela Albertelli ◽  
...  
Keyword(s):  
Neuroendocrine Tumors ◽  
Multicenter Study ◽  
Somatostatin Analogs ◽  
Stone Disease ◽  
Biliary Stone

Hemmkörperentwicklung bei Hämophilie-Patienten nach Präparate wechsel

2012 ◽  
Vol 32 (S 01) ◽  
pp. S39-S42 ◽  
Author(s):  
S. Kocher ◽  
G. Asmelash ◽  
V. Makki ◽  
S. Müller ◽  
S. Krekeler ◽  
...  
Keyword(s):  
Risk Factors ◽  
Risk Factor ◽  
Observational Study ◽  
Retrospective Observational Study ◽  
Frequent Change ◽  
Patient Age ◽  
Treatment Regimens ◽  
Patient Âgé ◽  
The Relationship ◽  
Observation Period

SummaryThe retrospective observational study surveys the relationship between development of inhibitors in the treatment of haemophilia patients and risk factors such as changing FVIII products. A total of 119 patients were included in this study, 198 changes of FVIII products were evaluated. Results: During the observation period of 12 months none of the patients developed an inhibitor, which was temporally associated with a change of FVIII products. A frequent change of FVIII products didn’t lead to an increase in inhibitor risk. The change between plasmatic and recombinant preparations could not be confirmed as a risk factor. Furthermore, no correlation between treatment regimens, severity, patient age and comorbidities of the patients could be found.

Sign in / Sign up

Export Citation Format

Share Document